Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
暂无分享,去创建一个
R. Cowan | N. Slevin | J. Roberts | S. Owens | C. Collins | P. Hillel | R. Cooper | E. Allan | S. Jeans | N. Gupta
[1] W. Brenner,et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine , 1996, Nuclear medicine communications.
[2] J. Johnson,et al. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. , 1995, International journal of radiation oncology, biology, physics.
[3] A. Davies,et al. A comparison of artificial saliva and pilocarpine in radiation induced xerostomia , 1994, The Journal of Laryngology & Otology.
[4] F. Hilgers,et al. Scintigraphic assessment of salivary function and excretion response in radiation‐induced injury of the major salivary glands , 1994, Cancer.
[5] B. Ferguson. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer , 1994 .
[6] S. Dische,et al. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] J. Rieke,et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Joensuu,et al. Pilocarpine and carbacholine in treatment of radiation-induced xerostomia. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] L. Patton,et al. Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[10] K. Clausen,et al. Treatment of radiation side effects with oral pilocarpine , 1989, Journal of surgical oncology.
[11] T. Daniels,et al. Effectiveness of pilocarpine in postradiation xerostomia , 1987, Cancer.
[12] Hirohiko Tsuni. Quantitative dose-response analysis of salivary function following radiotherapy using sequential RI-sialography , 1985 .
[13] H. Tsujii. Quantitative dose-response analysis of salivary function following radiotherapy using sequential RI-sialography. , 1985, International journal of radiation oncology, biology, physics.
[14] A. N. Nieuw Amerongen,et al. Influence of autonomic agonists on the in vitro incorporation of [3H]leucine and N-acetyl[14C]mannosamine into submandibular action of the mouse. , 1984, Biochimica et biophysica acta.
[15] L. Tabak,et al. Role of salivary mucins in the protection of the oral cavity. , 1982, Journal of oral pathology.
[16] W. B. Wescott,et al. Some factors influencing salivary function when treating with radiotherapy. , 1981, International journal of radiation oncology, biology, physics.
[17] D. Herbert,et al. The function of the parotid gland following radiation therapy for head and neck cancer. , 1981, International Journal of Radiation Oncology, Biology, Physics.
[18] C. Dawes,et al. The Relative Contributions of Different Salivary Glands to the Blood Group Activity of Whole Saliva in Humans , 1973, Vox sanguinis.
[19] R. Frank,et al. ACQUIRED DENTAL DEFECTS AND SALIVARY GLAND LESIONS AFTER IRRADIATION FOR CARCINOMA. , 1965, Journal of the American Dental Association.